Organ transplant is an issue that is dealt with across the globe. In each and every country, there are many people who die while waiting for a proper organ that is suitable for them. In case of bone marrow transplant, it is often seen that the donated marrow gets rejected quiet a lot times, which makes it very hard to find a perfect match.
Now scientists in New Zealand are working on a drug that would come as a boon for all the patients in need of a bone marrow transplant. Auckland University's Professor Bill Denny and Dr. Julie Spicer are part of a group that is working on the research led by the Peter MacCallum Cancer Centre in Melbourne. They are developing a drug to stop the body from rejecting bone marrow transplants in cancer patients.
Recently, they got a breakthrough after they discovered a protein called perforin. This protein works to get rid the body of cancerous cells, but it is also responsible for the rejection of the bone marrow during the treatment by triggering the immune system. With this discovery, the scientists have come one step closer to develop a drug that would solve the problem faced during transplant of Bone marrow.
Good News USA
- Vodafone NZ’s new ‘Red Home’ packages will offer UFB and 150 TV channels
- Vodafone NZ’s full-year profit plunged by more than two-thirds to $56 million
- Vodafone adding 34 European countries to ‘AU$5 per day’ international roaming option
- Telstra launches its new ‘Every Day Connect Data Share Packages’
- Voyager signs “multimillion-dollar deal” with submarine cable group Hawaiki